News

Risk for melanoma, the most deadly skin cancer, can be estimated long before detection of any suspicious moles, according to a UC San Francisco scientist who led a new study to detect DNA mutations in individual skin cells. Skin damage from the sun builds up over time but is often not obvious to the

Most parents know or suspect when their child smokes, but they are much more likely to be in the dark if the child vapes or uses other tobacco products, according to a large national study by researchers at UC San Francisco. The study, which tracked more than 23,000 participants aged 12 to 17 years

Though cancer immunotherapy has become a promising standard-of-care treatment—and in some cases, perhaps a cure—for a wide variety of different cancers, it doesn’t work for everyone, and researchers have increasingly turned their attention to understanding why. For example, doctors have noticed that

With 34,210 new diagnoses projected this year in the United States, 1 meningiomas are the most common primary brain tumor. While the majority of meningiomas are low grade and typically respond well to surgery and radiotherapy, high grade meningiomas are still poorly understood and often recur

On October 4th, Alain Algazi, MD, a melanoma specialist and head-and-neck cancer researcher at UCSF, will join friends and colleagues in running a marathon across SF and Marin to benefit the American Cancer Society. The ambitious 26.5 mile course will begin at the Hi Dive Bar under the Bay Bridge

As we continue to cope with the ongoing coronavirus pandemic nationwide, a second public health crisis is emerging and causing increasing alarm. Stemming from the initial deferrals of routine care as the pandemic took hold, combined with shelter-in-place health orders and the fears generated by

A malignant tumor is a bustling metropolis populated by many different kinds of cancer cells. This cellular diversity, however, is what makes cancer so difficult to treat, as each type of cell in a tumor responds differently – and sometimes not at all – to cancer therapies. This is especially true